Rebecca Pellett Madan

Rebecca Pellett Madan

Auto-generated profile, based on publicly available information

Rebecca Pellett Madan

Division of Pediatric Infectious Diseases, New York University Grossman School of Medicine, 424 East 34th Street, New York, NY, 10016, United States

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2019 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
RMRebecca Pellett Madan
Rebecca Pellett Madan
JHJonathan M. Hand
Jonathan M. Hand
TPthe AST Infectious Diseases Community of Practice
the AST Infectious Diseases Community of Practice

2 February 2021 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
STSarah Taimur
Sarah Taimur
SPStephanie M. Pouch
Stephanie M. Pouch
NZNicole Zubizarreta
Nicole Zubizarreta
MMMadhu Mazumdar
Madhu Mazumdar
MRMeenakshi Rana
Meenakshi Rana
SHShirish Huprikar
Shirish Huprikar

1 May 2021 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
ADAriel Daube
Ariel Daube
SRScott Rickert
Scott Rickert
RMRebecca Pellett Madan
Rebecca Pellett Madan
PKPhilip Kahn
Philip Kahn
JRJoanne Rispoli
Joanne Rispoli
HDHeda Dapul
Heda Dapul

1 November 2015 in AIDS Research and Human Retroviruses
Verified
Journal Article
Open access
RMRebecca Pellett Madan
Rebecca Pellett Madan
LMLindi Masson
Lindi Masson
JTJessica Tugetman
Jessica Tugetman
LWLise Werner
Lise Werner
AGAnneke Grobler
Anneke Grobler
BHBetsy C. Herold
Betsy C. Herold
Greater inhibitory activity against Escherichia coli and levels of human β defensin (HBD)-2 in genital tract secretions predicted HIV acquisition in women in the HPTN 035 trial. We investigated whether higher levels of E. coli inhibitory activity and antimicrobial peptides in cervicovaginal lavage (CVL) samples predicted HIV acquisition in women in the CAPRISA 002 Acute Infection Study. E. coli inhibitory activity and antimicrobial peptides were quantified in CVL from a subset of CAPRISA 002 participants who did not seroconvert ( n =39) and from seroconverting women prior to infection ( n =17) and during acute infection ( n =11). Women who acquired HIV had significantly greater preinfection CVL E. coli inhibitory activity ( p =0.01) and HBD-1 levels ( p =0.02) compared to women who remained uninfected. Preinfection E. coli inhibitory activity remained significantly associated with seroconversion following adjustment for the presence of bacterial vaginosis (OR 1.45; 95% CI 1.07, 1.97). Partial least squares discriminant analysis confirmed that preinfection CVL E. coli inhibitory activity, together with higher CVL concentrations of HBD-1 and secretory leukocyte protease inhibitor, distinguished seroconverters from nonseroconverters with 67% calibration accuracy. CVL concentrations of human neutrophil peptides (HNP) 1–3 increased significantly with acute infection ( p =0.001) and correlated with plasma viral set point ( r =0.66, p =0.03). E. coli inhibitory activity in genital tract secretions could provide a biomarker of HIV risk. The correlation between HNP 1–3 and viral set point merits further investigation of the relationship between mucosal inflammation during early HIV infection and disease progression.

23 June 2019 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
EBEsther Benamu
Esther Benamu
MPMarcus R. Pereira
Marcus R. Pereira
STSarah Taimur
Sarah Taimur
SJSamantha Jacobs
Samantha Jacobs
AFAmy L. Friedman
Amy L. Friedman
RMRebecca Pellett Madan
Rebecca Pellett Madan

26 November 2012 in American Journal of Reproductive Immunology
Verified
Journal Article
Open access
PDF file
RMRebecca Pellett Madan
Rebecca Pellett Madan
BHBetsy C. Herold
Betsy C. Herold
The risk of male to female transmission of HIV is impacted by baseline inflammation in the female genital tract, semen viral load and seminal plasma's ability to induce specific patterns of cervical cytokine signalling and influx of immune cell populations. Disruption of the epithelial barrier during non‐consensual intercourse may trigger further inflammation and initiation of cell‐signalling pathways, thus facilitating transmission of HIV and expansion of local infection. Adolescent and pregnant women are at high risk for sexual violence and may exhibit alterations of genital mucosal immunity that promote immune activation, making them uniquely vulnerable to HIV acquisition.